Shandong Luoxin Pharmaceutical Group Overview
- Year Founded
-
1996
- Status
-
Public
- Employees
-
6,000
- Investments
-
2
- Share Price
-
$2.11
- (As of Wednesday Closing)
Shandong Luoxin Pharmaceutical Group General Information
Description
Manufacturer of pharmaceutical products intended for the innovative drug development industry. The company offers tegoprazan tablets, fosaprepitant dimeglumine for injection, ambroxol hydrochloride spray, digestive and respiratory system drugs, anti tumour medications and cardiovascular drugs, thereby enabling healthcare providers to treat medical conditions through pharmaceutical research and freeze dried powder injection technology.
Contact Information
Website
www.luoxin.cnCorporate Office
- Luoqi Road, Linyi National High-tech Industrial Development Zone
- Linyi, Shandong 200126
- China
Corporate Office
- Luoqi Road, Linyi National High-tech Industrial Development Zone
- Linyi, Shandong 200126
- China
Shandong Luoxin Pharmaceutical Group Stock Performance
As of 31-May-2017, Shandong Luoxin Pharmaceutical Group’s stock price is $2.11. Its current market cap is $1.29B with 610M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.11 | $1.52 | $1.48 - $2.11 | $1.29B | 610M | 9K | $0.97 |
Shandong Luoxin Pharmaceutical Group Financials Summary
As of 31-Dec-2018, Shandong Luoxin Pharmaceutical Group has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Dec-2018 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 | FY 2016 31-Dec-2016 |
|---|---|---|---|---|
| Revenue | 1,400,000 | 618,697 | ||
| EBITDA | 80,902 | |||
| Net Income | 56,977 | |||
| Total Assets | 629,015 | |||
| Total Debt | 0 |
Shandong Luoxin Pharmaceutical Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Shandong Luoxin Pharmaceutical Group Comparisons
Industry
Financing
Details
Shandong Luoxin Pharmaceutical Group Competitors (28)
One of Shandong Luoxin Pharmaceutical Group’s 28 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA |
Shandong Luoxin Pharmaceutical Group Patents
Shandong Luoxin Pharmaceutical Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026067510-A1 | Tegoprazan injection and preparation method therefor | Pending | 29-Sep-2024 | ||
| WO-2026051923-A1 | Tegoprazan pyroglutamate injection and preparation method therefor | Pending | 04-Sep-2024 | ||
| WO-2022016420-A1 | Quinazolinone compound crystal form, preparation method therefor, and use thereof | Inactive | 22-Jul-2020 | ||
| WO-2021047466-A1 | Crystal form of p53-mdm2 inhibitor and preparation method therefor | Inactive | 12-Sep-2019 | ||
| WO-2021042890-A1 | Heterocyclic compound and application thereof as trk kinase inhibitor | Inactive | 04-Sep-2019 |
Shandong Luoxin Pharmaceutical Group Signals
Shandong Luoxin Pharmaceutical Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Shandong Luoxin Pharmaceutical Group Investments (2)
Shandong Luoxin Pharmaceutical Group’s most recent deal was a Corporate with Luoxin Health Technology for . The deal was made on 20-Apr-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Luoxin Health Technology | 20-Apr-2022 | Corporate | Medical Supplies | ||
| Luoxin Aurovitas Pharma | 25-Mar-2019 | Joint Venture | Medical Supplies |
Shandong Luoxin Pharmaceutical Group Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Luoxin Health Technology | Beijing, China | 2020 |
Shandong Luoxin Pharmaceutical Group FAQs
-
When was Shandong Luoxin Pharmaceutical Group founded?
Shandong Luoxin Pharmaceutical Group was founded in 1996.
-
Where is Shandong Luoxin Pharmaceutical Group headquartered?
Shandong Luoxin Pharmaceutical Group is headquartered in Linyi, China.
-
What is the size of Shandong Luoxin Pharmaceutical Group?
Shandong Luoxin Pharmaceutical Group has 6,000 total employees.
-
What industry is Shandong Luoxin Pharmaceutical Group in?
Shandong Luoxin Pharmaceutical Group’s primary industry is Pharmaceuticals.
-
Is Shandong Luoxin Pharmaceutical Group a private or public company?
Shandong Luoxin Pharmaceutical Group is a Public company.
-
What is the current stock price of Shandong Luoxin Pharmaceutical Group?
As of 31-May-2017 the stock price of Shandong Luoxin Pharmaceutical Group is $2.11.
-
What is the current market cap of Shandong Luoxin Pharmaceutical Group?
The current market capitalization of Shandong Luoxin Pharmaceutical Group is $1.29B.
-
Who are Shandong Luoxin Pharmaceutical Group’s competitors?
Pfizer (Vienna), Pfizer Pakistan, Evonile Pharma, Merck & Co., and Genentech are some of the 28 competitors of Shandong Luoxin Pharmaceutical Group.
-
What is Shandong Luoxin Pharmaceutical Group’s annual earnings per share (EPS)?
Shandong Luoxin Pharmaceutical Group’s EPS for 12 months was $0.97.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process